Motif ID | Motif Logo | Scanned Score Distribution | Frequency of Motif | Replicability Score | Evolutionary Conservation Score | Gene Targets | Gene Ontology of CpGMM targets |
---|---|---|---|---|---|---|---|
CG_imr90r1_promoter_p_PM_20_18_25 | ![]() |
![]() |
2 | 1.0 | 5.41E-05 | PDZD3 | negative regulation of cGMP biosynthetic process [BP], guanylate cyclase inhibitor activity [MF], subapical complex [CC], negative regulation of guanylate cyclase activity [BP] |
CG_imr90r1_promoter_p_PM_16_29_14 | ![]() |
![]() |
2 | 1.0 | 6.16E-05 | LCK, PRPS1, ACADS | butyrate catabolic process [BP], CD8 receptor binding [MF], butyryl-CoA dehydrogenase activity [MF], urate biosynthetic process [BP] |
CG_imr90r1_promoter_p_PM_12_157_7 | ![]() |
![]() |
2 | 1.0 | 6.77E-05 | APOE | positive regulation of low-density lipoprotein particle receptor catabolic process [BP], metal chelating activity [MF] |
CG_imr90r1_promoter_p_PM_14_23_3 | ![]() |
![]() |
1 | 0.5 | 3.03E-05 | CTNNB1 | beta-catenin-TCF7L2 complex [CC], positive regulation of heparan sulfate proteoglycan biosynthetic process [BP], renal inner medulla development [BP], canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [BP], canonical Wnt receptor signaling pathway involved in negative regulation of apoptotic process [BP], regulation of centriole-centriole cohesion [BP], glial cell fate determination [BP], positive regulation of epithelial cell proliferation involved in prostate gland development [BP], positive regulation of branching involved in lung morphogenesis [BP], renal outer medulla development [BP], Scrib-APC-beta-catenin complex [CC], canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition [BP] |
CG_imr90r1_promoter_p_PM_12_100_4 | ![]() |
![]() |
1 | 0.5 | 9.94E-05 | SMARCB1, SUPT6H, CUL4A, SLC25A4, SMARCAD1 | chromatin remodeling [BP], virus-host interaction [BP] |
CG_imr90r1_promoter_p_PM_12_21_4 | ![]() |
![]() |
2 | 1.0 | 1.55E-04 | CALD1, FBXL2, EPB41, RHBG | spectrin-associated cytoskeleton [CC], calmodulin binding [MF] |
CG_imr90r1_promoter_p_PM_12_67_7 | ![]() |
![]() |
2 | 1.0 | 9.28E-05 | POLA1, GREM1, PRKCI | negative regulation of bone mineralization involved in bone maturation [BP], negative regulation of bone trabecula formation [BP], leading strand elongation [BP], polarisome [CC] |
CG_imr90r1_promoter_p_PM_12_44_8 | ![]() |
![]() |
1 | 0.5 | 1.14E-04 | AGPAT5, SP140, TYMS | nuclear envelope [CC], thymidylate synthase activity [MF], immortalization of host cell by virus [BP], dTMP biosynthetic process [BP] |
CG_imr90r1_promoter_p_PM_12_163_4 | ![]() |
![]() |
2 | 1.0 | 3.43E-04 | FOXP2 | caudate nucleus development [BP], vocal learning [BP], putamen development [BP] |
CG_imr90r1_promoter_p_PM_20_17_29 | ![]() |
![]() |
1 | 0.5 | 7.96E-05 | TIRAP, RIN3, UBA5, SGSM3, RAPGEFL1, ECT2 | positive regulation of chemokine (C-X-C motif) ligand 1 production [BP], positive regulation of interleukin-15 production [BP], guanyl-nucleotide exchange factor activity [MF], TIRAP-dependent toll-like receptor 4 signaling pathway [BP], Rab GTPase binding [MF], GTPase activator activity [MF], UFM1 activating enzyme activity [MF], Toll-like receptor 2 binding [MF] |
CG_imr90r1_promoter_p_PM_18_24_12 | ![]() |
![]() |
1 | 0.5 | 5.11E-05 | BABAM1, ILF3, FAM175B | M phase [BP], BRISC complex [CC] |
CG_imr90r1_promoter_p_PM_12_48_8 | ![]() |
![]() |
1 | 0.5 | 1.18E-04 | RGCC | negative regulation of exit from mitosis [BP], regulation of M/G1 transition of mitotic cell cycle [BP] |
CG_imr90r1_promoter_p_PM_12_153_6 | ![]() |
![]() |
1 | 0.5 | 1.07E-05 | EIF4H, LOC81691, PA2G4, EIF3J | translation [BP], translational initiation [BP], translation initiation factor activity [MF], translation factor activity, nucleic acid binding [MF], RNA binding [MF] |
CG_imr90r1_promoter_p_PM_12_79_4 | ![]() |
![]() |
1 | 0.5 | 2.42E-05 | ING3, ST3GAL6 | Piccolo NuA4 histone acetyltransferase complex [CC], beta-galactoside alpha-2,3-sialyltransferase activity [MF] |
CG_imr90r1_promoter_p_PM_12_28_9 | ![]() |
![]() |
2 | 1.0 | 1.73E-05 | TFAM, DHX30 | transcription initiation from mitochondrial promoter [BP], mitochondrial light strand promoter sense binding [MF], mitochondrial nucleoid [CC] |
CG_imr90r1_promoter_p_PM_16_24_14 | ![]() |
![]() |
1 | 0.5 | 3.80E-05 | POR | negative regulation of lipase activity [BP] |
CG_imr90r1_promoter_p_PM_18_15_20 | ![]() |
![]() |
2 | 1.0 | 2.67E-05 | PLK4, CD4 | protein palmitoleylation [BP], positive regulation of centriole replication [BP], induction by virus of host cell-cell fusion [BP] |
CG_imr90r1_promoter_p_PM_20_14_37 | ![]() |
![]() |
2 | 1.0 | 1.14E-04 | KPNA2, DAG1, AACS | adipose tissue development [BP], NLS-bearing substrate import into nucleus [BP] |
CG_imr90r1_promoter_p_PM_14_28_12 | ![]() |
![]() |
2 | 1.0 | 4.57E-06 | SQRDL, FPGS | tetrahydrofolylpolyglutamate synthase activity [MF], sulfide:quinone oxidoreductase activity [MF] |
CG_imr90r1_promoter_p_PM_18_21_19 | ![]() |
![]() |
2 | 1.0 | 8.53E-05 | LGALS1, PSMD11, REST, RAC1, COL14A1 | negative regulation of amniotic stem cell differentiation [BP], negative regulation of dense core granule biogenesis [BP], negative regulation of mesenchymal stem cell differentiation [BP], positive regulation of erythrocyte aggregation [BP], T cell costimulation [BP], viral reproduction [BP], collagen type XIV [CC] |
CG_imr90r1_promoter_p_PM_14_48_7 | ![]() |
![]() |
2 | 1.0 | 3.44E-05 | ATP7A, NAGS, ARID1A | nucleosome mobilization [BP], copper ion export [BP], acetyl-CoA:L-glutamate N-acetyltransferase activity [MF], detoxification of copper ion [BP], negative regulation of metalloenzyme activity [BP] |
CG_imr90r1_promoter_p_PM_20_3_7 | ![]() |
![]() |
1 | 0.5 | 1.48E-04 | NFKB1 | negative regulation of interleukin-12 biosynthetic process [BP] |
CG_imr90r1_promoter_p_PM_12_151_5 | ![]() |
![]() |
1 | 0.5 | 7.83E-05 | ASNA1, D2HGDH, TMBIM6, RAB10, HSD11B2, SRP54 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [BP], (R)-2-hydroxyglutarate dehydrogenase activity [MF], establishment of protein localization to endoplasmic reticulum membrane [BP], SRP-dependent cotranslational protein targeting to membrane, translocation [BP], detoxification of arsenic-containing substance [BP], endoplasmic reticulum [CC], GDP binding [MF] |
CG_imr90r1_promoter_p_PM_12_127_12 | ![]() |
![]() |
2 | 1.0 | 2.77E-05 | HCRTR1 | orexin receptor activity [MF] |
CG_imr90r1_promoter_p_PM_14_17_4 | ![]() |
![]() |
2 | 1.0 | 2.71E-05 | JAM3 | regulation of actin cytoskeleton organization by cell-cell adhesion [BP] |
CG_imr90r1_promoter_p_PM_20_9_16 | ![]() |
![]() |
2 | 1.0 | 2.26E-05 | NT5M, USP10, KIAA1324, NAA60, SLC1A4 | L-hydroxyproline transmembrane transporter activity [MF], positive regulation of autophagic vacuole assembly [BP], L-threonine transmembrane transporter activity [MF], threonine transport [BP], dUMP catabolic process [BP], N-terminal peptidyl-methionine acetylation [BP], hydroxyproline transport [BP], regulation of autophagy [BP], positive regulation of vacuole organization [BP] |
CG_imr90r1_promoter_p_PM_12_36_4 | ![]() |
![]() |
1 | 0.5 | 2.08E-04 | ACADM, PDSS1, GGPS1, F2R | medium-chain fatty acid catabolic process [BP], isoprenoid biosynthetic process [BP], negative regulation of renin secretion into blood stream [BP], geranylgeranyl diphosphate biosynthetic process [BP] |
CG_imr90r1_promoter_p_PM_16_3_5 | ![]() |
![]() |
1 | 0.5 | 4.59E-05 | CRHBP, MAVS | negative regulation of corticotropin-releasing hormone receptor activity [BP], negative regulation of corticotropin secretion [BP], positive regulation of IP-10 production [BP] |
CG_imr90r1_promoter_p_PM_18_23_11 | ![]() |
![]() |
2 | 1.0 | 1.45E-04 | ZRSR2, PDZK1, CRCP | pre-mRNA 3'-splice site binding [MF], DNA polymerase III complex [CC], scavenger receptor binding [MF], calcitonin gene-related polypeptide receptor activity [MF] |
CG_imr90r1_promoter_p_PM_12_149_6 | ![]() |
![]() |
1 | 0.5 | 1.25E-04 | PEX14, KIF2C, MTUS2 | microtubule binding [MF], cytoplasmic microtubule [CC] |
CG_imr90r1_promoter_p_PM_16_13_37 | ![]() |
![]() |
1 | 0.5 | 1.67E-05 | ACCS, GCAT | glycine C-acetyltransferase activity [MF], pyridoxal phosphate binding [MF], L-threonine catabolic process to glycine [BP] |
CG_imr90r1_promoter_p_PM_12_58_2 | ![]() |
![]() |
1 | 0.5 | 1.26E-04 | RPL23A, MAPRE2, PCNT | olfactory bulb development [BP], cell proliferation [BP] |
CG_imr90r1_promoter_p_PM_14_46_4 | ![]() |
![]() |
2 | 1.0 | 4.56E-05 | MARCH5 | positive regulation of mitochondrial fission [BP] |
CG_imr90r1_promoter_p_PM_12_2_5 | ![]() |
![]() |
1 | 0.5 | 2.32E-05 | PCIF1, TRMU | half bridge of spindle pole body [CC], sulfurtransferase activity [MF], tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase activity [MF] |
CG_imr90r1_promoter_p_PM_14_29_14 | ![]() |
![]() |
2 | 1.0 | 4.56E-05 | TRIM22, TRIM8 | protein ubiquitination [BP] |
CG_imr90r1_promoter_p_PM_12_25_7 | ![]() |
![]() |
1 | 0.5 | 2.06E-05 | LDLRAP1 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport [BP], clathrin adaptor activity [MF] |
CG_imr90r1_promoter_p_PM_20_6_21 | ![]() |
![]() |
2 | 1.0 | 4.43E-05 | PIN1, RAB11B, FKBP6, PIM1, NKTR | peptidyl-prolyl cis-trans isomerase activity [MF], cell cycle [BP] |
CG_imr90r1_promoter_p_PM_12_56_6 | ![]() |
![]() |
1 | 0.5 | 1.26E-05 | SPTBN1, RAB8A | Golgi vesicle fusion to target membrane [BP], membrane assembly [BP] |
CG_imr90r1_promoter_p_PM_12_33_8 | ![]() |
![]() |
1 | 0.5 | 9.75E-05 | GSG2 | histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [BP], histone kinase activity (H3-T3 specific) [MF] |
CG_imr90r1_promoter_p_PM_12_123_6 | ![]() |
![]() |
1 | 0.5 | 1.08E-04 | SGCA, PVRL2 | susceptibility to T cell mediated cytotoxicity [BP], virion attachment, binding of host cell surface coreceptor [BP], cell-cell junction [CC], sperm mitochondrion organization [BP] |
CG_imr90r1_promoter_p_PM_12_143_8 | ![]() |
![]() |
2 | 1.0 | 1.59E-04 | PTPN1, PRKCA | negative regulation of insulin receptor signaling pathway [BP], positive regulation of dense core granule biogenesis [BP] |
CG_imr90r1_promoter_p_PM_12_124_4 | ![]() |
![]() |
2 | 1.0 | 1.54E-04 | AZU1, PNPLA3 | positive regulation of fractalkine biosynthetic process [BP], mono-olein transacylation activity [MF], positive regulation of interleukin-1 beta biosynthetic process [BP], diolein transacylation activity [MF] |
CG_imr90r1_promoter_p_PM_14_21_16 | ![]() |
![]() |
3 | 1.0 | 9.03E-05 | BCKDHA, RHO | photoreceptor inner segment membrane [CC], 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [MF], red, far-red light phototransduction [BP], alpha-ketoacid dehydrogenase activity [MF] |
CG_imr90r1_promoter_p_PM_14_51_10 | ![]() |
![]() |
2 | 1.0 | 4.67E-05 | NF2, PDE4A | negative regulation of tyrosine phosphorylation of Stat5 protein [BP], ruffle membrane [CC] |
CG_imr90r1_promoter_p_PM_20_21_14 | ![]() |
![]() |
2 | 1.0 | 3.42E-05 | RPS27, RPL28, MRPS21, RPL14 | structural constituent of ribosome [MF], ribosome [CC], translational termination [BP] |
CG_imr90r1_promoter_p_PM_12_162_5 | ![]() |
![]() |
1 | 0.5 | 2.02E-04 | PPARA | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter [BP], regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter [BP], regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter [BP] |
CG_imr90r1_promoter_p_PM_16_37_4 | ![]() |
![]() |
1 | 0.5 | 1.87E-05 | ST3GAL3, SH2B2, B3GNT4 | keratan sulfate metabolic process [BP], N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF], O-glycan processing [BP], keratan sulfate biosynthetic process [BP], JAK pathway signal transduction adaptor activity [MF], glycosaminoglycan metabolic process [BP] |
CG_imr90r1_promoter_p_PM_12_160_4 | ![]() |
![]() |
2 | 1.0 | 2.46E-04 | PTDSS2 | CDP-diacylglycerol-serine O-phosphatidyltransferase activity [MF] |
CG_imr90r1_promoter_p_PM_12_145_5 | ![]() |
![]() |
2 | 1.0 | 1.04E-04 | MLL | positive regulation of cellular response to drug [BP] |
CG_imr90r1_promoter_p_PM_12_34_2 | ![]() |
![]() |
1 | 0.5 | 2.13E-05 | MDM2, PSMD4 | cellular response to vitamin B1 [BP], cellular response to UV-C [BP], DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [BP] |
CG_imr90r1_promoter_p_PM_14_2_9 | ![]() |
![]() |
3 | 1.0 | 3.25E-05 | RBL2, CDKN1A, SOX17, POLR3D, DBF4, CDHR2, GNL3 | G1 phase of mitotic cell cycle [BP], nucleoplasm [CC], negative regulation of cell growth [BP], cyclin-dependent protein kinase activating kinase activity [MF] |
CG_imr90r1_promoter_p_PM_14_40_7 | ![]() |
![]() |
2 | 1.0 | 1.14E-04 | GRB7, DDX1 | RNA helicase activity [MF], cytoplasmic stress granule [CC] |
CG_imr90r1_promoter_p_PM_12_147_7 | ![]() |
![]() |
1 | 0.5 | 5.16E-05 | VIL1 | cytoplasmic actin-based contraction involved in cell motility [BP], lysophosphatidic acid binding [MF], regulation of lamellipodium morphogenesis [BP] |
CG_imr90r1_promoter_p_PM_14_45_12 | ![]() |
![]() |
2 | 1.0 | 1.78E-05 | PTPN11, SH2B2, EIF3B, MERTK, ISCU | SH3/SH2 adaptor activity [MF], protein complex scaffold [MF], negative regulation of growth hormone secretion [BP], rhabdomere [CC], negative regulation of cortisol secretion [BP], nitrogen fixation [BP] |
CG_imr90r1_promoter_p_PM_12_119_12 | ![]() |
![]() |
1 | 0.5 | 3.73E-05 | ACAD10 | acyl-CoA dehydrogenase activity [MF] |
CG_imr90r1_promoter_p_PM_14_22_8 | ![]() |
![]() |
1 | 0.5 | 3.40E-05 | ACOT4 | unsaturated monocarboxylic acid metabolic process [BP], saturated monocarboxylic acid metabolic process [BP], succinyl-CoA hydrolase activity [MF] |
CG_imr90r1_promoter_p_PM_12_166_9 | ![]() |
![]() |
1 | 0.5 | 4.67E-04 | GAPDH | peptidyl-cysteine S-nitrosylase activity [MF], peptidyl-cysteine S-trans-nitrosylation [BP], glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [MF] |
CG_imr90r1_promoter_p_PM_14_50_7 | ![]() |
![]() |
1 | 0.5 | 3.53E-05 | RIMS1, RAB8A | regulation of long-term neuronal synaptic plasticity [BP] |
CG_imr90r1_promoter_p_PM_12_39_7 | ![]() |
![]() |
1 | 0.5 | 5.98E-05 | RSAD2 | positive regulation of toll-like receptor 7 signaling pathway [BP], positive regulation of toll-like receptor 9 signaling pathway [BP] |
CG_imr90r1_promoter_p_PM_16_4_36 | ![]() |
![]() |
2 | 1.0 | 8.88E-05 | ALOX5AP, IQGAP1, ECT2, PIP5K1A | cellular response to calcium ion [BP], activation of Rac GTPase activity [BP] |
CG_imr90r1_promoter_p_PM_12_57_7 | ![]() |
![]() |
2 | 1.0 | 2.57E-04 | C11orf82 | negative regulation of fibroblast apoptotic process [BP] |
CG_imr90r1_promoter_p_PM_12_29_8 | ![]() |
![]() |
1 | 0.5 | 9.75E-06 | NOP58 | snRNP protein import into nucleus [BP] |
CG_imr90r1_promoter_p_PM_12_164_9 | ![]() |
![]() |
1 | 0.5 | 5.70E-05 | BCKDHB | 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [MF], mitochondrial alpha-ketoglutarate dehydrogenase complex [CC], alpha-ketoacid dehydrogenase activity [MF] |
CG_imr90r1_promoter_p_PM_16_2_11 | ![]() |
![]() |
3 | 1.0 | 3.91E-05 | ADK, HEXB | male courtship behavior [BP], dATP biosynthetic process [BP], adenosine kinase activity [MF] |
CG_imr90r1_promoter_p_PM_16_14_14 | ![]() |
![]() |
2 | 1.0 | 4.18E-05 | DCAF10, SLC47A1 | monovalent cation:hydrogen antiporter activity [MF], Cul4-RING ubiquitin ligase complex [CC] |
CG_imr90r1_promoter_p_PM_12_64_9 | ![]() |
![]() |
1 | 0.5 | 1.34E-04 | TAF1B, KLF11, TDG, KDM1A, DOLPP1 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity [MF], negative regulation of histone H3-K4 methylation [BP], RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity [MF], dolichyl diphosphate biosynthetic process [BP], RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript [BP], dolichyldiphosphatase activity [MF], negative regulation of protein binding [BP], transcription regulatory region DNA binding [MF], RNA polymerase I CORE element sequence-specific DNA binding [MF], RNA polymerase I core factor complex [CC], regulation of transcription involved in S phase of mitotic cell cycle [BP], regulation of primitive erythrocyte differentiation [BP] |
CG_imr90r1_promoter_p_PM_14_7_7 | ![]() |
![]() |
1 | 0.5 | 4.78E-05 | PPIG, SKI, CDK12 | histone deacetylase inhibitor activity [MF], nuclear body [CC], nuclear speck [CC], cyclin K-CDK12 complex [CC], phosphorylation of RNA polymerase II C-terminal domain [BP] |
CG_imr90r1_promoter_p_PM_12_71_4 | ![]() |
![]() |
1 | 0.5 | 9.08E-05 | MAPRE1 | cortical microtubule cytoskeleton [CC] |
CG_imr90r1_promoter_p_PM_16_5_11 | ![]() |
![]() |
1 | 0.5 | 2.47E-05 | SNX9, RBM4, ATP2A1, CAMSAP3 | circadian regulation of translation [BP], relaxation of skeletal muscle [BP], IRES-dependent translational initiation [BP], cap-independent translational initiation [BP], elevation of endoplasmic reticulum calcium ion concentration [BP], pre-mRNA intronic pyrimidine-rich binding [MF], lipid tube assembly [BP], microtubule minus-end binding [MF], positive regulation of fast-twitch skeletal muscle fiber contraction [BP], H zone [CC] |
CG_imr90r1_promoter_p_PM_18_20_37 | ![]() |
![]() |
2 | 1.0 | 3.15E-05 | CHST12, XYLT2, NCKAP1L, NCAN | chondroitin sulfate biosynthetic process [BP], T cell homeostasis [BP], dermatan sulfate biosynthetic process [BP], glycosaminoglycan biosynthetic process [BP] |
CG_imr90r1_promoter_p_PM_14_20_9 | ![]() |
![]() |
4 | 1.0 | 4.83E-05 | POLR2C, KIF1C, GEN1, POLB, FBXO6, UNG, SCFD1 | retrograde vesicle-mediated transport, Golgi to ER [BP], DNA repair [BP] |
CG_imr90r1_promoter_p_PM_14_5_8 | ![]() |
![]() |
2 | 1.0 | 5.46E-05 | OAZ1 | polyamine biosynthetic process [BP] |
CG_imr90r1_promoter_p_PM_12_75_7 | ![]() |
![]() |
2 | 1.0 | 1.94E-05 | PHKG2 | phosphorylase kinase complex [CC] |
CG_imr90r1_promoter_p_PM_12_90_5 | ![]() |
![]() |
1 | 0.5 | 2.04E-04 | CYP46A1, NR2F2, BMPR1A | radial pattern formation [BP], paraxial mesoderm structural organization [BP], cholesterol 24-hydroxylase activity [MF], neural plate mediolateral regionalization [BP] |
CG_imr90r1_promoter_p_PM_20_10_11 | ![]() |
![]() |
2 | 1.0 | 3.65E-05 | CDC16, BAMBI, TUBG2, EP300, GCDH, NCKAP1L | spindle microtubule [CC], protein polymerization [BP], glutaryl-CoA dehydrogenase activity [MF], negative regulation of myosin-light-chain-phosphatase activity [BP], positive regulation of CD8-positive, alpha-beta T cell differentiation [BP], positive regulation of protein binding [BP], SCAR complex [CC] |
CG_imr90r1_promoter_p_PM_12_50_5 | ![]() |
![]() |
1 | 0.5 | 8.46E-05 | PGAM1 | regulation of pentose-phosphate shunt [BP] |
CG_imr90r1_promoter_p_PM_12_115_4 | ![]() |
![]() |
1 | 0.5 | 1.68E-04 | LTBP4, CD36, ACVR2A, PGM5 | transforming growth factor beta binding [MF], lipoteichoic acid receptor activity [MF], transforming growth factor beta-activated receptor activity [MF], spot adherens junction [CC], transmembrane receptor protein serine/threonine kinase activity [MF], growth factor binding [MF] |
CG_imr90r1_promoter_p_PM_12_101_8 | ![]() |
![]() |
2 | 1.0 | 1.06E-04 | SCYL2, CAV1, CENPF | receptor internalization involved in canonical Wnt receptor signaling pathway [BP], metaphase plate congression [BP] |
CG_imr90r1_promoter_p_PM_16_34_14 | ![]() |
![]() |
2 | 1.0 | 5.69E-05 | SMARCB1, COL14A1, RAD50, GRN, PSMC6, INTS3 | blastocyst hatching [BP], protein binding, bridging [MF], G2/M transition checkpoint [BP] |
CG_imr90r1_promoter_p_PM_16_38_6 | ![]() |
![]() |
1 | 0.5 | 3.28E-05 | FTL, TRNT1 | tRNA 3'-terminal CCA addition [BP], ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [MF], CTP:3'-cytidine-tRNA cytidylyltransferase activity [MF], tRNA nucleotidyltransferase activity [MF], CTP:tRNA cytidylyltransferase activity [MF], tRNA adenylyltransferase activity [MF], tRNA 3'-end processing [BP], intracellular ferritin complex [CC] |
CG_imr90r1_promoter_p_PM_18_14_7 | ![]() |
![]() |
1 | 0.5 | 4.23E-05 | ECM1, GREM1 | negative regulation of bone mineralization [BP] |
CG_imr90r1_promoter_p_PM_18_7_27 | ![]() |
![]() |
2 | 1.0 | 8.32E-05 | ANGPTL3, NT5M, ANXA4, DECR2, MSI2 | phospholipase inhibitor activity [MF], nucleotide binding [MF] |
CG_imr90r1_promoter_p_PM_20_20_28 | ![]() |
![]() |
2 | 1.0 | 3.88E-05 | NIT1, UBIAD1 | menaquinone biosynthetic process [BP], nitrilase activity [MF] |
CG_imr90r1_promoter_p_PM_12_43_10 | ![]() |
![]() |
1 | 0.5 | 7.41E-05 | NCKAP1L, MYOD1, MADD | positive regulation of CD8-positive, alpha-beta T cell differentiation [BP], negative regulation of myosin-light-chain-phosphatase activity [BP], positive regulation of myoblast fusion [BP], protein kinase activator activity [MF], SCAR complex [CC] |
CG_imr90r1_promoter_p_PM_12_148_5 | ![]() |
![]() |
2 | 1.0 | 6.65E-06 | RBCK1, IL13 | interleukin-13 receptor binding [MF], positive regulation of connective tissue growth factor production [BP], positive regulation of lung goblet cell differentiation [BP], negative regulation of lung ciliated cell differentiation [BP], positive regulation of pancreatic stellate cell proliferation [BP], LUBAC complex [CC], protein linear polyubiquitination [BP], positive regulation of tyrosine phosphorylation of Stat6 protein [BP] |
CG_imr90r1_promoter_p_PM_12_134_5 | ![]() |
![]() |
2 | 1.0 | 1.12E-04 | NBR1, CEL, ATG7, TRIM24 | protein esterification [BP], APG12 activating enzyme activity [MF], intestinal lipid catabolic process [BP], perichromatin fibrils [CC], macroautophagy [BP] |
CG_imr90r1_promoter_p_PM_12_69_4 | ![]() |
![]() |
2 | 1.0 | 1.79E-04 | ANK2 | T-tubule organization [BP], membrane depolarization involved in regulation of SA node cell action potential [BP], positive regulation of potassium ion transmembrane transporter activity [BP] |
CG_imr90r1_promoter_p_PM_12_24_14 | ![]() |
![]() |
2 | 1.0 | 1.41E-04 | MLL, THTPA | metal ion binding [MF], thiamin-triphosphatase activity [MF], positive regulation of cellular response to drug [BP] |
CG_imr90r1_promoter_p_PM_16_36_7 | ![]() |
![]() |
1 | 0.5 | 6.40E-05 | DNASE1, NF2, HSPA2 | synaptonemal complex disassembly [BP], positive regulation of cyclin-dependent protein kinase activity involved in G2/M [BP], negative regulation of tyrosine phosphorylation of Stat5 protein [BP], deoxyribonuclease I activity [MF] |
CG_imr90r1_promoter_p_PM_14_12_8 | ![]() |
![]() |
1 | 0.5 | 4.78E-05 | CXADR, SPATA13 | cell adhesion molecule binding [MF], filopodium [CC], adherens junction [CC] |
CG_imr90r1_promoter_p_PM_12_59_7 | ![]() |
![]() |
1 | 0.5 | 2.17E-05 | PLOD1, PPIF | hydroxylysine biosynthetic process [BP], procollagen-lysine 5-dioxygenase activity [MF], negative regulation of oxidative phosphorylation uncoupler activity [BP], negative regulation of oxidative phosphorylation [BP], regulation of proton-transporting ATPase activity, rotational mechanism [BP] |
CG_imr90r1_promoter_p_PM_12_89_3 | ![]() |
![]() |
1 | 0.5 | 2.63E-04 | SLC35A1, NEIL1 | negative regulation of nuclease activity [BP], CMP-N-acetylneuraminate transport [BP], CMP-N-acetylneuraminate transmembrane transporter activity [MF] |
CG_imr90r1_promoter_p_PM_12_62_4 | ![]() |
![]() |
1 | 0.5 | 2.04E-05 | NDFIP1, PKN3, PRKCA | protein kinase C activity [MF], regulation of myeloid leukocyte differentiation [BP] |
CG_imr90r1_promoter_p_PM_12_65_4 | ![]() |
![]() |
2 | 1.0 | 7.73E-05 | JAK2 | histone kinase activity (H3-Y41 specific) [MF], mineralocorticoid receptor signaling pathway [BP], histone H3-Y41 phosphorylation [BP], activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [BP] |
CG_imr90r1_promoter_p_PM_12_52_3 | ![]() |
![]() |
1 | 0.5 | 6.70E-05 | UBA5, OXSM, RGCC, NAGK | N-acetylglucosamine kinase activity [MF], UFM1 activating enzyme activity [MF], negative regulation of exit from mitosis [BP], regulation of M/G1 transition of mitotic cell cycle [BP], medium-chain fatty acid biosynthetic process [BP] |
CG_imr90r1_promoter_p_PM_14_32_9 | ![]() |
![]() |
2 | 1.0 | 3.81E-05 | TPST1, PMAIP1 | peptidyl-tyrosine sulfation [BP], negative regulation of mitochondrial membrane potential [BP], protein-tyrosine sulfotransferase activity [MF] |
CG_imr90r1_promoter_p_PM_20_1_24 | ![]() |
![]() |
2 | 1.0 | 4.51E-05 | RBM4, PIWIL2, TNRC6A, GATAD2A, ILF3, HDAC1 | NuRD complex [CC], negative regulation of translation involved in gene silencing by miRNA [BP], ribonucleoprotein complex [CC], gene silencing by RNA [BP] |
CG_imr90r1_promoter_p_PM_14_33_14 | ![]() |
![]() |
3 | 1.0 | 2.03E-05 | SGIP1 | positive regulation of energy homeostasis [BP], positive regulation of feeding behavior [BP] |
CG_imr90r1_promoter_p_PM_12_120_6 | ![]() |
![]() |
1 | 0.5 | 1.79E-04 | CDK5R2, PAFAH1B1 | establishment of centrosome localization [BP], astral microtubule [CC], hippocampus development [BP], layer formation in cerebral cortex [BP], cerebral cortex development [BP], positive regulation of mitotic cell cycle [BP] |
CG_imr90r1_promoter_p_PM_14_36_15 | ![]() |
![]() |
2 | 1.0 | 2.36E-05 | ZNF205, CDC42, C11orf73 | apolipoprotein A-I receptor binding [MF], submandibular salivary gland formation [BP], positive regulation of hair follicle cell proliferation [BP], Golgi organization [BP], actin filament branching [BP], positive regulation of mitochondrial outer membrane permeabilization [BP], positive regulation of hydrogen peroxide biosynthetic process [BP] |
CG_imr90r1_promoter_p_PM_20_11_28 | ![]() |
![]() |
2 | 1.0 | 6.53E-05 | HSD17B12, TRAF7, PRCC, RABEPK, CALML6, CDH1, HSD17B6, PRKCI | estradiol 17-beta-dehydrogenase activity [MF], Schmidt-Lanterman incisure [CC], intracellular membrane-bounded organelle [CC] |
CG_imr90r1_promoter_p_PM_12_85_5 | ![]() |
![]() |
2 | 1.0 | 3.48E-05 | PDXK, CRHBP, PPARD | linoleic acid binding [MF], pyridoxal 5'-phosphate salvage [BP], lithium ion binding [MF], negative regulation of corticotropin-releasing hormone receptor activity [BP], pyridoxal kinase activity [MF], pyridoxal phosphate biosynthetic process [BP], negative regulation of corticotropin secretion [BP] |
CG_imr90r1_promoter_p_PM_14_9_7 | ![]() |
![]() |
2 | 1.0 | 3.57E-05 | ADPRHL2 | poly(ADP-ribose) glycohydrolase activity [MF] |
CG_imr90r1_promoter_p_PM_14_37_13 | ![]() |
![]() |
1 | 0.5 | 5.11E-05 | MDM2, SERPING1, SPHK1, TRIM22, PINK1 | protein ubiquitination [BP], C3HC4-type RING finger domain binding [MF], negative regulation of protein processing [BP], D-erythro-sphingosine kinase activity [MF], cellular response to toxin [BP], cellular response to UV-C [BP], negative regulation of endopeptidase activity [BP], negative regulation of complement activation, lectin pathway [BP], response to stress [BP], cellular response to vitamin B1 [BP], sphinganine kinase activity [MF], negative regulation of apoptotic process [BP], positive regulation of mitotic cell cycle [BP], sphingoid catabolic process [BP] |
CG_imr90r1_promoter_p_PM_12_70_6 | ![]() |
![]() |
1 | 0.5 | 4.32E-05 | TGS1, AMH | ribonucleoprotein complex import into nucleus [BP], preantral ovarian follicle growth [BP], RNA trimethylguanosine synthase activity [MF], 7-methylguanosine cap hypermethylation [BP] |
CG_imr90r1_promoter_p_PM_12_126_8 | ![]() |
![]() |
2 | 1.0 | 3.82E-05 | CARNS1 | carnosine synthase activity [MF], carnosine biosynthetic process [BP] |
CG_imr90r1_promoter_p_PM_16_31_13 | ![]() |
![]() |
2 | 1.0 | 1.92E-04 | NIT1 | nitrilase activity [MF] |
CG_imr90r1_promoter_p_PM_12_125_6 | ![]() |
![]() |
1 | 0.5 | 5.52E-06 | BLOC1S3, B3GALT6 | secretion of lysosomal enzymes [BP], endosome to melanosome transport [BP], Golgi medial cisterna [CC], galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF], platelet dense granule organization [BP] |
CG_imr90r1_promoter_p_PM_16_35_14 | ![]() |
![]() |
2 | 1.0 | 1.76E-05 | SIPA1L1 | activation of Rap GTPase activity [BP] |
CG_imr90r1_promoter_p_PM_14_26_3 | ![]() |
![]() |
1 | 0.5 | 6.61E-05 | GGPS1 | farnesyl diphosphate biosynthetic process [BP], geranyl diphosphate biosynthetic process [BP], dimethylallyltranstransferase activity [MF], geranyltranstransferase activity [MF], geranylgeranyl diphosphate biosynthetic process [BP] |
CG_imr90r1_promoter_p_PM_18_22_9 | ![]() |
![]() |
1 | 0.5 | 3.62E-05 | FOXA3, SMARCB1, HPN, ZIC2 | positive regulation by host of viral transcription [BP], regulation of sequence-specific DNA binding transcription factor activity [BP], positive regulation of sequence-specific DNA binding transcription factor activity [BP] |
CG_imr90r1_promoter_p_PM_12_7_8 | ![]() |
![]() |
1 | 0.5 | 1.51E-04 | SCP2D1, IL1RN, JAM3, L3MBTL1, ING5, CCDC64 | SAM domain binding [MF], methylated histone residue binding [MF], interleukin-1 Type I receptor antagonist activity [MF], interleukin-1 Type II receptor antagonist activity [MF], Golgi to secretory granule transport [BP], regulation of actin cytoskeleton organization by cell-cell adhesion [BP], sterol binding [MF] |
CG_imr90r1_promoter_p_PM_12_47_6 | ![]() |
![]() |
2 | 1.0 | 4.74E-05 | OGDH | oxoglutarate dehydrogenase complex [CC], oxoglutarate dehydrogenase (NAD+) activity [MF], olfactory bulb mitral cell layer development [BP] |
CG_imr90r1_promoter_p_PM_16_17_8 | ![]() |
![]() |
2 | 1.0 | 5.88E-05 | RBM3, GMPR, PVRL2 | response to cold [BP], flagellum organization [BP] |
CG_imr90r1_promoter_p_PM_12_74_4 | ![]() |
![]() |
1 | 0.5 | 2.40E-04 | SIVA1, SLC20A1 | CD27 receptor binding [MF], high affinity inorganic phosphate:sodium symporter activity [MF] |
CG_imr90r1_promoter_p_PM_12_122_4 | ![]() |
![]() |
2 | 1.0 | 2.47E-05 | SPAST, NUP85 | spindle [CC] |
CG_imr90r1_promoter_p_PM_12_87_4 | ![]() |
![]() |
1 | 0.5 | 1.05E-04 | ETV2, PCYOX1 | chloride-transporting ATPase activity [MF], blastocyst development [BP], prenylcysteine oxidase activity [MF], BMP signaling pathway involved in mesodermal cell fate specification [BP] |
CG_imr90r1_promoter_p_PM_20_8_23 | ![]() |
![]() |
2 | 1.0 | 6.57E-05 | CCND1, EIF4G1, MOCOS, BAX, MOCS3, ZNF703, CNOT8, PRELP, NPM1, EIF4A2, MORC3 | molybdopterin cofactor biosynthetic process [BP], cell aging [BP], positive regulation of mammary gland epithelial cell proliferation [BP], eukaryotic translation initiation factor 4F complex [CC], molybdopterin cofactor metabolic process [BP], Mo-molybdopterin cofactor biosynthetic process [BP], regulation of mammary gland epithelial cell proliferation [BP], mammary gland epithelial cell proliferation [BP], nuclear-transcribed mRNA poly(A) tail shortening [BP] |
CG_imr90r1_promoter_p_PM_12_109_6 | ![]() |
![]() |
1 | 0.5 | 1.10E-04 | ABAT | 4-aminobutyrate transaminase complex [CC], 4-aminobutyrate transaminase activity [MF], (S)-3-amino-2-methylpropionate transaminase activity [MF], succinate-semialdehyde dehydrogenase binding [MF] |
CG_imr90r1_promoter_p_PM_12_41_5 | ![]() |
![]() |
2 | 1.0 | 2.59E-04 | CIDEA, SMAD3 | negative regulation of transforming growth factor beta receptor signaling pathway [BP], positive regulation of transforming growth factor beta3 production [BP] |
CG_imr90r1_promoter_p_PM_18_13_5 | ![]() |
![]() |
1 | 0.5 | 4.58E-05 | TADA2B, DNASE1, CDK1 | pronuclear fusion [BP], deoxyribonuclease I activity [MF], SAGA-type complex [CC] |
CG_imr90r1_promoter_p_PM_20_13_24 | ![]() |
![]() |
2 | 1.0 | 2.93E-05 | NCAN, PPARA, NCKAP1L, CHST12 | dermatan sulfate biosynthetic process [BP], chondroitin sulfate biosynthetic process [BP], negative regulation of myosin-light-chain-phosphatase activity [BP], positive regulation of CD8-positive, alpha-beta T cell differentiation [BP], regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter [BP], regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter [BP], SCAR complex [CC] |
CG_imr90r1_promoter_p_PM_12_81_4 | ![]() |
![]() |
1 | 0.5 | 2.39E-04 | PPP2R4 | protein tyrosine phosphatase activator activity [MF] |
CG_imr90r1_promoter_p_PM_20_7_13 | ![]() |
![]() |
2 | 1.0 | 3.20E-05 | IL20RB, SLC1A3, GRIN1 | glutamate binding [MF], immune response-inhibiting signal transduction [BP] |
CG_imr90r1_promoter_p_PM_12_51_2 | ![]() |
![]() |
1 | 0.5 | 4.49E-05 | INHBB | negative regulation of hepatocyte growth factor biosynthetic process [BP], host cell surface receptor binding [MF] |
CG_imr90r1_promoter_p_PM_14_31_4 | ![]() |
![]() |
2 | 1.0 | 1.57E-05 | ZNRF3 | Wnt receptor catabolic process [BP] |
CG_imr90r1_promoter_p_PM_16_25_7 | ![]() |
![]() |
2 | 1.0 | 4.14E-05 | AGBL5 | protein branching point deglutamylation [BP] |
CG_imr90r1_promoter_p_PM_16_7_13 | ![]() |
![]() |
2 | 1.0 | 6.42E-05 | ID4, PLP1 | central nervous system myelination [BP] |
CG_imr90r1_promoter_p_PM_14_38_4 | ![]() |
![]() |
1 | 0.5 | 6.43E-05 | ZNF205, ADM, SDHAF2 | protein-FAD linkage [BP], positive regulation of hydrogen peroxide biosynthetic process [BP], adrenomedullin receptor binding [MF], positive regulation of mitochondrial outer membrane permeabilization [BP] |
CG_imr90r1_promoter_p_PM_12_128_4 | ![]() |
![]() |
1 | 0.5 | 1.33E-04 | PI4K2A | host cell presynaptic membrane [CC], basophil degranulation [BP] |
CG_imr90r1_promoter_p_PM_16_32_18 | ![]() |
![]() |
2 | 1.0 | 2.03E-05 | AVPR1B | regulation of systemic arterial blood pressure by vasopressin [BP] |
CG_imr90r1_promoter_p_PM_18_18_25 | ![]() |
![]() |
3 | 1.0 | 4.19E-05 | PCSK9, MINK1 | response to stress [BP], cellular response to starvation [BP] |
CG_imr90r1_promoter_p_PM_12_78_6 | ![]() |
![]() |
2 | 1.0 | 5.07E-05 | TIAM2, TRMT61A, INPP5J, XRN2, ARHGEF7 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [MF], 5'-3' exoribonuclease activity [MF], tRNA (adenine-N1-)-methyltransferase activity [MF], neuron projection [CC], Rho guanyl-nucleotide exchange factor activity [MF] |
CG_imr90r1_promoter_p_PM_12_138_5 | ![]() |
![]() |
1 | 0.5 | 2.23E-05 | BHMT2, NANS | N-acylneuraminate-9-phosphate synthase activity [MF], N-acylneuraminate cytidylyltransferase activity [MF], N-acetylneuraminate synthase activity [MF], betaine-homocysteine S-methyltransferase activity [MF] |
CG_imr90r1_promoter_p_PM_12_154_5 | ![]() |
![]() |
1 | 0.5 | 6.43E-05 | ST3GAL3, AKR1E2, CDK5R1, FOXD4L1, ALDOA, APC, FOXP2 | 1,5-anhydro-D-fructose reductase activity [MF], putamen development [BP], N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF], muscle cell homeostasis [BP], cerebral cortex development [BP], caudate nucleus development [BP], cerebellum development [BP], DNA binding, bending [MF] |
CG_imr90r1_promoter_p_PM_12_107_8 | ![]() |
![]() |
1 | 0.5 | 3.71E-05 | AKAP13, PANX1 | leak channel activity [MF], regulation of glucocorticoid mediated signaling pathway [BP] |
CG_imr90r1_promoter_p_PM_12_116_5 | ![]() |
![]() |
2 | 1.0 | 1.51E-04 | MDM2, UCHL1, HTR6 | cellular response to peptide hormone stimulus [BP], cellular response to vitamin B1 [BP], neuromuscular process [BP], cellular response to UV-C [BP], negative regulation of acetylcholine secretion [BP], negative regulation of gamma-aminobutyric acid secretion [BP] |
CG_imr90r1_promoter_p_PM_12_88_7 | ![]() |
![]() |
2 | 1.0 | 2.45E-04 | IL23A, LBP | positive regulation of respiratory burst involved in inflammatory response [BP], leukocyte chemotaxis involved in inflammatory response [BP], defense response to Gram-negative bacterium [BP], positive regulation of tumor necrosis factor production [BP], positive regulation of inflammatory response [BP], positive regulation of neutrophil chemotaxis [BP] |
CG_imr90r1_promoter_p_PM_18_19_22 | ![]() |
![]() |
2 | 1.0 | 2.46E-05 | MINK1, SPHK1, KCNK1, MELK, PTPRE, PCDHGC3, BMPR2, TTLL10, PNN, APLP2, SERPINB2, GNAI2, TAOK1, ERBB2 | protein phosphorylation [BP], plasma membrane [CC] |
CG_imr90r1_promoter_p_PM_12_12_4 | ![]() |
![]() |
1 | 0.5 | 3.83E-05 | VEGFB | positive regulation of vascular wound healing [BP], vascular endothelial growth factor receptor 1 binding [MF] |
CG_imr90r1_promoter_p_PM_12_156_9 | ![]() |
![]() |
2 | 1.0 | 7.69E-05 | DNAH8, ZRANB1, ARL6, NUDT1 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process [BP], cilium axoneme [CC], ATP diphosphatase activity [MF] |
CG_imr90r1_promoter_p_PM_12_103_7 | ![]() |
![]() |
1 | 0.5 | 8.94E-05 | ACTN4 | positive regulation of pinocytosis [BP] |
CG_imr90r1_promoter_p_PM_12_135_6 | ![]() |
![]() |
1 | 0.5 | 1.83E-04 | SLC11A1, NLGN3 | divalent metal ion export [BP], metal ion:hydrogen antiporter activity [MF], regulation of terminal button organization [BP], cellular cadmium ion homeostasis [BP], nitrite transport [BP], tertiary granule membrane [CC] |
CG_imr90r1_promoter_p_PM_12_91_8 | ![]() |
![]() |
1 | 0.5 | 2.25E-04 | RASL10B | regulation of systemic arterial blood pressure by atrial natriuretic peptide [BP] |
CG_imr90r1_promoter_p_PM_14_18_17 | ![]() |
![]() |
1 | 0.5 | 3.97E-05 | GIPR | gastric inhibitory peptide receptor activity [MF] |
CG_imr90r1_promoter_p_PM_20_23_23 | ![]() |
![]() |
2 | 1.0 | 6.25E-05 | ACER3, IFITM1, IL6R, IKBKG, CCL20, MSX2, SPPL2B, HM13, ACER2 | positive regulation of osteoblast differentiation [BP], integral to cytosolic side of endoplasmic reticulum membrane [CC], aspartic endopeptidase activity, intramembrane cleaving [MF], immune response [BP], sphingosine biosynthetic process [BP], ceramidase activity [MF] |
CG_imr90r1_promoter_p_PM_12_114_9 | ![]() |
![]() |
2 | 1.0 | 6.70E-05 | SLC30A7, KIF26A, NTSR1, SLC39A2 | zinc ion transport [BP], G-protein coupled neurotensin receptor activity [MF], regulation of cell growth by extracellular stimulus [BP] |
CG_imr90r1_promoter_p_PM_12_13_13 | ![]() |
![]() |
2 | 1.0 | 2.23E-05 | ENO3, F2RL1 | negative regulation of toll-like receptor 3 signaling pathway [BP], positive regulation of cytokine secretion involved in immune response [BP], phosphopyruvate hydratase complex [CC], positive regulation of eosinophil degranulation [BP], positive regulation of toll-like receptor 3 signaling pathway [BP], positive regulation of glomerular filtration [BP], positive regulation of toll-like receptor 2 signaling pathway [BP], chemokine (C-C motif) ligand 2 secretion [BP], positive regulation of phagocytosis, engulfment [BP], positive regulation of neutrophil mediated killing of gram-negative bacterium [BP], negative regulation of chemokine secretion [BP], positive regulation of renin secretion into blood stream [BP] |
CG_imr90r1_promoter_p_PM_12_10_5 | ![]() |
![]() |
1 | 0.5 | 2.33E-04 | CR1, CAPN3, RAB10 | complement component C4b binding [MF], positive regulation of satellite cell activation involved in skeletal muscle regeneration [BP], positive regulation of serine-type endopeptidase activity [BP], negative regulation of complement activation, alternative pathway [BP], autolysis [BP], complement component C3b receptor activity [MF], establishment of protein localization to endoplasmic reticulum membrane [BP], complement component C4b receptor activity [MF], self proteolysis [BP], G1 to G0 transition involved in cell differentiation [BP], negative regulation of protein sumoylation [BP], complement component C3b binding [MF], negative regulation of serine-type endopeptidase activity [BP], negative regulation of complement activation, classical pathway [BP] |
CG_imr90r1_promoter_p_PM_12_97_8 | ![]() |
![]() |
2 | 1.0 | 3.32E-05 | LDLRAP1 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport [BP], internal side of plasma membrane [CC], clathrin adaptor activity [MF] |
CG_imr90r1_promoter_p_PM_12_4_3 | ![]() |
![]() |
2 | 1.0 | 4.16E-05 | MLH1, LTC4S | chiasma [CC], negative regulation of mitotic recombination [BP], spindle midzone assembly involved in meiosis [BP], meiotic metaphase I plate congression [BP], leukotriene-C4 synthase activity [MF], MutLbeta complex [CC] |
CG_imr90r1_promoter_p_PM_16_19_12 | ![]() |
![]() |
1 | 0.5 | 3.82E-05 | EPHX2, TCF21, RAN | 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [MF], androgen receptor binding [MF], stilbene catabolic process [BP], androgen receptor signaling pathway [BP], 4-nitrophenylphosphatase activity [MF] |
CG_imr90r1_promoter_p_PM_16_15_10 | ![]() |
![]() |
1 | 0.5 | 3.09E-05 | HGS, RPS6KB1 | response to leucine [BP], intracellular membrane-bounded organelle [CC] |
CG_imr90r1_promoter_p_PM_12_142_5 | ![]() |
![]() |
1 | 0.5 | 1.52E-04 | ROMO1, RIPK1, LPL, PI4K2A, FTO, NR1H3, RARA | apoptotic cell clearance [BP], triglyceride homeostasis [BP], host cell presynaptic membrane [CC], regulation of ATP:ADP antiporter activity [BP], negative regulation of secretion of lysosomal enzymes [BP], ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], oxidative DNA demethylase activity [MF], AP-3 adaptor complex binding [MF], regulation of lipid storage [BP], positive regulation of reactive oxygen species metabolic process [BP], Sertoli cell fate commitment [BP], basophil degranulation [BP] |
CG_imr90r1_promoter_p_PM_12_152_7 | ![]() |
![]() |
1 | 0.5 | 1.70E-05 | DAND5 | sequestering of nodal from receptor via nodal binding [BP], determination of left/right asymmetry in lateral mesoderm [BP], negative regulation of nodal signaling pathway [BP] |
CG_imr90r1_promoter_p_PM_16_6_12 | ![]() |
![]() |
2 | 1.0 | 2.83E-05 | PLK4, CCP110, UGP2 | centrosome duplication [BP], centriole replication [BP], UTP:glucose-1-phosphate uridylyltransferase activity [MF], positive regulation of centriole replication [BP], centriole [CC] |
CG_imr90r1_promoter_p_PM_12_8_7 | ![]() |
![]() |
1 | 0.5 | 1.17E-04 | ING2, TLR2 | lipoteichoic acid binding [MF], Toll-like receptor 2-Toll-like receptor 6 protein complex [CC], diacyl lipopeptide binding [MF], male germ-line stem cell division [BP], cellular response to triacyl bacterial lipopeptide [BP], positive regulation of interleukin-18 production [BP], CCAAT-binding factor complex [CC], response to molecule of fungal origin [BP], detection of diacyl bacterial lipopeptide [BP], triacyl lipopeptide binding [MF], cell surface pattern recognition receptor signaling pathway [BP], induction by symbiont of defense-related host nitric oxide production [BP], Toll-like receptor 1-Toll-like receptor 2 protein complex [CC], cellular response to diacyl bacterial lipopeptide [BP], chloramphenicol transport [BP], cellular response to peptidoglycan [BP], detection of triacyl bacterial lipopeptide [BP] |
CG_imr90r1_promoter_p_PM_12_117_12 | ![]() |
![]() |
2 | 1.0 | 6.78E-05 | YWHAH | glucocorticoid catabolic process [BP] |
CG_imr90r1_promoter_p_PM_12_68_8 | ![]() |
![]() |
2 | 1.0 | 7.56E-05 | EIF5, KHDRBS1 | Grb2-Sos complex [CC], regulation of translational initiation [BP] |
CG_imr90r1_promoter_p_PM_12_15_4 | ![]() |
![]() |
2 | 1.0 | 7.54E-05 | STAT5A | positive regulation of mast cell differentiation [BP] |
CG_imr90r1_promoter_p_PM_14_16_3 | ![]() |
![]() |
2 | 1.0 | 1.79E-04 | TOP1, CSGALNACT2 | replication fork protection complex [CC], chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [BP], glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [MF], dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [BP] |
CG_imr90r1_promoter_p_PM_14_13_10 | ![]() |
![]() |
2 | 1.0 | 8.60E-05 | C5AR1, GCDH, L3MBTL1 | glutaryl-CoA dehydrogenase activity [MF], SAM domain binding [MF], complement component C5a binding [MF] |
CG_imr90r1_promoter_p_PM_12_86_6 | ![]() |
![]() |
1 | 0.5 | 4.41E-05 | KDM1A | regulation of primitive erythrocyte differentiation [BP] |
CG_imr90r1_promoter_p_PM_12_72_5 | ![]() |
![]() |
2 | 1.0 | 2.76E-04 | RQCD1, LSM14A | cytoplasmic mRNA processing body [CC] |
CG_imr90r1_promoter_p_PM_12_6_4 | ![]() |
![]() |
2 | 1.0 | 3.32E-04 | GSN, PLG | tissue regeneration [BP] |
CG_imr90r1_promoter_p_PM_20_26_84 | ![]() |
![]() |
2 | 1.0 | 3.99E-05 | WFS1, G6PC, FFAR1, HK1, ASPSCR1 | glucose 6-phosphate metabolic process [BP], glucose homeostasis [BP] |
CG_imr90r1_promoter_p_PM_12_38_11 | ![]() |
![]() |
2 | 1.0 | 8.64E-05 | TYRP1, PSAT1, GRK1, HCCS | regulation of rhodopsin mediated signaling pathway [BP], acetoacetic acid metabolic process [BP], holocytochrome-c synthase activity [MF], O-phospho-L-serine:2-oxoglutarate aminotransferase activity [MF] |
CG_imr90r1_promoter_p_PM_20_24_25 | ![]() |
![]() |
2 | 1.0 | 2.69E-05 | RAC1, POR | localization within membrane [BP], negative regulation of lipase activity [BP] |
CG_imr90r1_promoter_p_PM_14_47_3 | ![]() |
![]() |
2 | 1.0 | 1.33E-04 | RAD51, MDM2 | positive regulation of DNA ligation [BP], cellular response to vitamin B1 [BP], cellular response to UV-C [BP] |
CG_imr90r1_promoter_p_PM_14_10_8 | ![]() |
![]() |
2 | 1.0 | 4.16E-05 | FDFT1 | farnesyl-diphosphate farnesyltransferase activity [MF], squalene synthase activity [MF] |
CG_imr90r1_promoter_p_PM_14_39_5 | ![]() |
![]() |
1 | 0.5 | 2.82E-05 | FZD9, C5AR1, TCF7L1, CNTN2 | positive regulation of adenosine receptor signaling pathway [BP], establishment of protein localization to juxtaparanode region of axon [BP], complement component C5a binding [MF], brain development [BP], positive regulation of transcription from RNA polymerase II promoter during mitosis [BP] |
CG_imr90r1_promoter_p_PM_20_15_35 | ![]() |
![]() |
2 | 1.0 | 1.09E-04 | TMED2, COPG1, PACS1 | protein targeting to plasma membrane [BP], COPI coating of Golgi vesicle [BP], COPI-coated vesicle membrane [CC], COPI-coated vesicle [CC] |
CG_imr90r1_promoter_p_PM_18_27_7 | ![]() |
![]() |
1 | 0.5 | 2.01E-05 | SET, KAT8 | histone binding [MF], histone acetylation [BP] |
CG_imr90r1_promoter_p_PM_12_141_5 | ![]() |
![]() |
2 | 1.0 | 3.29E-04 | HSP90AB1 | dATP binding [MF], UTP binding [MF], CTP binding [MF], sulfonylurea receptor binding [MF] |
CG_imr90r1_promoter_p_PM_12_161_6 | ![]() |
![]() |
1 | 0.5 | 4.78E-05 | OTUB1 | NEDD8-specific protease activity [MF] |
CG_imr90r1_promoter_p_PM_14_4_10 | ![]() |
![]() |
2 | 1.0 | 1.44E-05 | AQP8 | intracellular canaliculus [CC] |
CG_imr90r1_promoter_p_PM_12_19_6 | ![]() |
![]() |
2 | 1.0 | 5.94E-05 | TPI1, MUC2, ICT1, SLC22A5 | sodium-dependent organic cation transport [BP], triose-phosphate isomerase activity [MF], translation release factor activity, codon nonspecific [MF], positive regulation of intestinal epithelial structure maintenance [BP], quorum sensing involved in interaction with host [BP], mitochondrial translational termination [BP], inner mucus layer [CC], outer mucus layer [CC] |
CG_imr90r1_promoter_p_PM_12_84_7 | ![]() |
![]() |
1 | 0.5 | 1.06E-05 | APOBEC3C, TET3 | DNA demethylation [BP], DNA demethylation of male pronucleus [BP] |
CG_imr90r1_promoter_p_PM_12_30_4 | ![]() |
![]() |
1 | 0.5 | 1.16E-04 | CSF2, AQP6 | nitrate transmembrane transporter activity [MF], granulocyte macrophage colony-stimulating factor receptor binding [MF] |
CG_imr90r1_promoter_p_PM_16_10_37 | ![]() |
![]() |
2 | 1.0 | 6.19E-05 | SLC39A13, SLC39A14, KIAA1967, CENPF, TCHP, MAP2K1, KPNA2, TCEANC, NLRP5 | G2 phase of mitotic cell cycle [BP], apical cortex [CC], regulation of DNA-dependent transcription, elongation [BP], zinc ion transmembrane transport [BP], spindle pole body [CC] |
CG_imr90r1_promoter_p_PM_20_25_45 | ![]() |
![]() |
1 | 0.5 | 3.87E-05 | TEK, BMPR2, GLP1R, HES1, CRHR1, AKAP5 | positive regulation of BMP signaling pathway [BP], positive regulation of cAMP biosynthetic process [BP], activation of adenylate cyclase activity [BP], glomerulus vasculature development [BP] |
CG_imr90r1_promoter_p_PM_14_43_4 | ![]() |
![]() |
1 | 0.5 | 2.27E-05 | TMED2, CYR61 | embryonic placenta development [BP], intussusceptive angiogenesis [BP], apoptotic process involved in heart morphogenesis [BP] |
CG_imr90r1_promoter_p_PM_14_35_5 | ![]() |
![]() |
2 | 1.0 | 2.64E-05 | RAB7A | epidermal growth factor catabolic process [BP], phagosome-lysosome fusion [BP], phagosome acidification [BP] |
CG_imr90r1_promoter_p_PM_12_110_5 | ![]() |
![]() |
2 | 1.0 | 4.57E-05 | PABPN1, PQBP1, EPHX1 | cis-stilbene-oxide hydrolase activity [MF], neuronal ribonucleoprotein granule [CC], modification by virus of host mRNA processing [BP] |
CG_imr90r1_promoter_p_PM_12_155_6 | ![]() |
![]() |
1 | 0.5 | 7.65E-05 | RPS6KA1, PAOX | N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF], N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF], N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF], positive regulation of hepatic stellate cell activation [BP], spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [MF], positive regulation of spermidine biosynthetic process [BP], spermine catabolic process [BP], spermidine catabolic process [BP] |
CG_imr90r1_promoter_p_PM_14_11_17 | ![]() |
![]() |
2 | 1.0 | 7.24E-05 | FKBP10, NFATC1 | FK506 binding [MF] |
CG_imr90r1_promoter_p_PM_12_104_4 | ![]() |
![]() |
1 | 0.5 | 1.97E-04 | MAT2B, ABP1 | diamine oxidase activity [MF], histamine oxidase activity [MF], cellular response to azide [BP], cellular response to copper ion starvation [BP], dTDP-4-dehydrorhamnose reductase activity [MF], methionine adenosyltransferase complex [CC], methylputrescine oxidase activity [MF], extracellular polysaccharide biosynthetic process [BP], methionine adenosyltransferase regulator activity [MF], propane-1,3-diamine oxidase activity [MF] |
CG_imr90r1_promoter_p_PM_14_41_3 | ![]() |
![]() |
1 | 0.5 | 2.03E-04 | PHAX, GGPS1 | farnesyl diphosphate biosynthetic process [BP], geranyl diphosphate biosynthetic process [BP], geranylgeranyl diphosphate biosynthetic process [BP], snRNA export from nucleus [BP] |
CG_imr90r1_promoter_p_PM_12_94_5 | ![]() |
![]() |
1 | 0.5 | 7.58E-05 | BGLAP, GPIHBP1, MAU2, LHX4, RAB11A | chylomicron binding [MF], structural constituent of bone [MF], plasma membrane to endosome transport [BP], medial motor column neuron differentiation [BP], positive regulation of chylomicron remnant clearance [BP], SMC loading complex [CC], response to hydroxyisoflavone [BP] |
CG_imr90r1_promoter_p_PM_12_105_7 | ![]() |
![]() |
1 | 0.5 | 1.11E-05 | GALR2 | galanin receptor activity [MF] |
CG_imr90r1_promoter_p_PM_12_31_5 | ![]() |
![]() |
2 | 1.0 | 1.02E-05 | FNTA, GALM | positive regulation of tubulin deacetylation [BP], aldose 1-epimerase activity [MF] |